We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VLYPP:NASDAQValley National Bancorp - 6.25% Fixed-to-Floating Rate Series A Non-Cumulative Perpetual Preferred Stock Analysis

Data as of 2026-05-09 - not real-time

$25.30

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Valley National Bancorp delivered a solid Q1 performance, beating revenue expectations with a double‑digit year‑over‑year increase and posting non‑GAAP earnings per share ahead of consensus. Operating margins near 46% and profit margins above 30% underscore strong profitability, while a dividend yield in the high single digits provides attractive income. The stock trades at a price‑to‑earnings multiple notably above the regional banking average, suggesting it is priced for growth. Technically, the price sits just above the 20‑day moving average and the bullish MACD crossover adds short‑term momentum, though volume is trending lower and the market is range‑bound between clear support and resistance levels. Low beta and moderate 30‑day volatility indicate limited price swings relative to the broader market, but the decreasing volume hints at potential liquidity constraints.
Looking ahead, the high dividend payout must be weighed against cash‑flow uncertainties and a balance sheet that carries substantial debt despite sizable cash reserves. The overvalued valuation metric combined with sector‑specific credit and regulatory headwinds tempers enthusiasm, yet the strong earnings trajectory and income appeal support a cautiously positive outlook. Investors may consider a modest exposure, favoring the dividend while monitoring liquidity and credit risk factors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Earnings beat and revenue acceleration
  • Bullish MACD signal
  • Attractive dividend yield

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation premium relative to peers
  • Moderate sector and regulatory risk
  • Potential liquidity constraints

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable high dividend income
  • Consistently strong operating margins
  • Low beta indicating defensive characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth23.80%
Profit Margin33.79%
P/E Ratio22.8
ROE8.56%
ROA1.04%
P/B Ratio1.9
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI54.8
Support$24.87
Resistance$25.39
MA 20$25.22
MA 50$25.06
MA 200$25.28
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73

Valuation

GradeOvervalued
TypeGrowth
Dividend Yield7.72%

Risk Assessment

Beta0.16
Volatility10.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.